GLP-1 receptor agonists are now widely used for weight loss and blood sugar control. With options like Mounjaro (tirzepatide), Ozempic (semaglutide), and Wegovy becoming more popular, many UK patients are asking the key question: which GLP-1 is the safest? At PPRX, we assess every patient individually to recommend the most effective and appropriate treatment — prioritising both safety and results.
What Are GLP-1 Medications?
GLP-1 stands for glucagon-like peptide-1, a hormone that helps regulate appetite, blood sugar, and digestion. GLP-1 medications mimic this hormone to:
- Slow gastric emptying
- Promote satiety
- Reduce food cravings
- Improve insulin sensitivity
These actions lead to sustained weight loss and better control of blood glucose, especially in people with obesity or type 2 diabetes.
Common GLP-1 Weight Loss Medications in the UK
- Ozempic (semaglutide): Approved for diabetes, used off-label for weight loss
- Wegovy (semaglutide): Approved for weight loss at a higher dose than Ozempic
- Mounjaro (tirzepatide): Newer dual GLP-1 and GIP agonist, approved for diabetes and increasingly prescribed for weight loss
Each works similarly, but with different strengths, dosing schedules, and tolerability profiles.
Which GLP-1 Has the Best Safety Record?
All GLP-1 medications carry similar safety profiles, and side effects are generally mild and manageable. However, tolerability and outcomes vary slightly:
- Ozempic and Wegovy: Proven safe in large clinical trials, but some patients experience ongoing nausea or plateauing results at higher doses
- Mounjaro (tirzepatide): Slightly more potent due to its dual action (GLP-1 and GIP), and often better tolerated during dose increases
In trials, tirzepatide led to greater average weight loss with comparable or lower rates of side effects compared to semaglutide.
What Side Effects Should You Watch For?
Most GLP-1 users experience temporary side effects such as:
- Nausea
- Constipation or diarrhoea
- Reduced appetite
- Mild fatigue or headaches
These typically resolve after the first few weeks or with slower dose escalation. Rare but serious risks include pancreatitis or gallbladder issues, which is why medications like Mounjaro should only be used under medical supervision.
How PPRX Ensures GLP-1 Safety
At PPRX, we don’t prescribe GLP-1 medications like Mounjaro or Ozempic unless you are medically eligible. We screen for:
- Current BMI and weight-related conditions
- Any history of thyroid cancer or pancreatitis
- Medication interactions and overall health risk
Our GPhC-registered pharmacists review every consultation before dispensing — and we offer full support through your weight loss journey.
Our Recommendation for Most UK Patients
While every case is different, many of our patients at PPRX find that Mounjaro offers the best balance of effectiveness and safety, especially for those with stubborn weight gain, PCOS, or poor results from other medications. Its dual-hormone mechanism often leads to fewer cravings and better overall outcomes.
👉 Check Your Eligibility for Mounjaro Now
At PPRX UK, we provide:
- Genuine Mounjaro pens, sourced directly from the manufacturer (Eli Lilly)
- Dispensing via a GPhC-registered UK pharmacy
- Professional consultations with UK pharmacists
- Ongoing support, dosage guidance, and repeat supply options
Whether you’re just starting or switching from Ozempic or Wegovy, we’re here to help.
📞 Get in Touch
Visit www.pprx.co.uk or contact us directly to begin your online consultation.
We offer fast, discreet UK-wide delivery and exceptional support throughout your journey.
Mounjaro is a prescription-only medicine. This article is for informational purposes only and does not replace medical advice. Always consult a qualified healthcare provider before starting treatment. nhs
